-+ 0.00%
-+ 0.00%
-+ 0.00%

The Tokyo Stock Exchange saw Canvas in a buying mood in the afternoon after receiving approval from the European Medicines Agency to start Phase 3 clinical trials.

NIKKEI QUICK·11/19/2026 04:47:03

Please log in to view news